Catalyst Wire Dossier Catalyst Wire Dossier

PTK787 (Vatalanib)

Vatalanib · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTK787 (Vatalanib), covering 2014-09-11 to 2014-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors [Phase 1]

See pricing